EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy and Safety of Penehyclidine Hydrochloride in Postoperative Nausea and Vomiting Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ahmed Magdy, Eithar Alqady, Mohamed Wagdy, Ahmed T.shalby, Mahmoud Abdelkader, Karim Osamy, Alaa Anter, IhabTarik, Manar Samy, Sherif Eltawansy, Ahmed Hassan

ASIDE Internal Medicine · 2025

DOI: 10.71079/aside.im.04272547 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ASIDE Internal Medicine, 2025. Verfasst von Ahmed Magdy und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Postoperative nausea and vomiting (PONV) is a common complication following anesthesia. Penehyclidine hydrochloride (PHC), an anticholinergic medication, selectively inhibits the M1 Muscarinic and M3 Muscarinic receptors involved in the nausea and vomiting pathways. This study aims to evaluate the efficacy of PHC in preventing PONV and its potential advantages over existing treatments.

Methods

This study investigated the efficacy and safety of PHC in preventing PONV by analyzing randomized controlled trials (RCTs) identified through a comprehensive search of the PubMed, Scopus, Web of Science, and Cochrane Library databases up to December 2024.

Results

Five RCTs involving 979 patients were included. Compared to the control group, PHC reduced the incidence of PONV in the first 24-72 hours after surgery (RR: 0.64, 95% CI [0.50, 0.82], p = 0.0004) and the requirement of rescue antiemetics (RR: 0.46, 95% CI [0.22, 0.96], p = 0.04). However, PHC significantly increased the incidence of dry mouth (RR: 2.64, 95% CI [1.98, 3.5], p < 0.00001). No significant differences were observed between the two groups regarding other secondary outcomes. Risk of bias assessment was done using RoB2.

Conclusions

PHC shows promising efficacy in reducing PONV and the need for antiemetic medications. Further large-scale RCTs are necessary to verify these results and determine the optimal dose.

Zitieren

APA

Magdy, A., Alqady, E., Wagdy, M., T.shalby, A., Abdelkader, M., Osamy, K., Anter, A., IhabTarik, Samy, M., Eltawansy, S., & Hassan, A. (2025). Efficacy and Safety of Penehyclidine Hydrochloride in Postoperative Nausea and Vomiting Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ASIDE Internal Medicine. https://doi.org/10.71079/aside.im.04272547

Vancouver

Magdy A, Alqady E, Wagdy M, T.shalby A, Abdelkader M, Osamy K, et al. Efficacy and Safety of Penehyclidine Hydrochloride in Postoperative Nausea and Vomiting Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ASIDE Internal Medicine. 2025. doi:10.71079/aside.im.04272547

BibTeX
@article{Magdy2025,
  author = {Magdy, Ahmed and Alqady, Eithar and Wagdy, Mohamed and T.shalby, Ahmed and Abdelkader, Mahmoud and Osamy, Karim and Anter, Alaa and IhabTarik and Samy, Manar and Eltawansy, Sherif and Hassan, Ahmed},
  title = {Efficacy and Safety of Penehyclidine Hydrochloride in Postoperative Nausea and Vomiting Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {ASIDE Internal Medicine},
  year = {2025},
  doi = {10.71079/aside.im.04272547}
}
Kostenlos starten →